Table 1:
Assessment | Baseline | 2, 4, 6 & 8 Months |
12 Months |
18 Months |
24 Months |
Transition | 1 Year post transition |
---|---|---|---|---|---|---|---|
Demographics | X | ||||||
Family Interview for Genetic Studies | X | ||||||
Cannon Spoor Premorbid Assessment of Functioning | X | ||||||
Childhood Brain Injury | X | ||||||
Structured Assessment of Violence Risk in Youth | X | ||||||
Childhood Trauma Questionnaire | X | ||||||
SCID-5 | X | X | X | ||||
Structured Interview for Psychosis-Risk Syndromes | X | X | X | X | X | X | X |
Scale of Psychosis Risk Symptoms | X | X | X | X | X | X | X |
Calgary Depression Scale for Schizophrenia (CDSS) | X | X | X | X | X | X | |
Alcohol/Drug Use Scale (AUS/DUS) | X | X | X | X | X | X | |
Global Functioning: Social and Role Scales | X | X | X | X | X | X | |
Cannabis Scale | X | ||||||
The PERI Life events scale | X | ||||||
Structured assessment of violence risk in youth | |||||||
Sleep Measure (PSQI-NH) | X | X | X | ||||
Daily Stress Inventory | X | X | X | X | |||
Neurocognitive Battery | X | X | X | ||||
Blood Draw and Urine Sample | X | X | X | X | |||
Cortisol/Saliva Sampling | X | X | X | X | X | ||
Electrophysiology | X | X | X | ||||
MRI | X | X | X |